Contribute
España
Italia
대한민국
日本
Français

Benzinga

Research
My Stocks
Tools
Free Benzinga Pro Trial
SPY
773.110.01%
QQQ
721.56-
BTC/USD
64206.890.4616%
DIA
538.410.11%
GLD
401.160.34%
TLT
81.750.38%

Puma Biotechnology Inc

PBYINASDAQ
Trade with Public
Trade with Public
$8.69
-0.22-2.47%
At close: Aug 7, 5:00 PM EST
$8.69
-0.22-2.47%
Pre-Market: 5:53 AM EST
Earnings: Q2 2026 Earnings were released on Thu Aug 6th, after the market close
Conference Call: The most recent conference call started at 4:30 PM, 5 days ago
Click to view the webcast
OverviewNewsEarnings ForecastEventsPrice TargetsFinancialsSentimentOwnershipCompareOptionsStock Report

Puma Biotechnology Analyst Price Targets

Wall Street analyst price targets and consensus rating for Puma Biotechnology (PBYI).

Price Target Range — 7 Quarters

Analyst Consensus — 2 Analysts

1Buy
1Hold
Consensus RatingBuy# Analysts2Avg. Consensus PT$7Upside to Avg. PT-25.2%

Rating Trend — Last 9 Months

Recent Analyst Actions

View all ratings →
DateFirmAnalystActionRating ChangePrice Target
Aug 7, 2026TD CowenMarc FrahmPT RaiseHold$5→$6
Feb 28, 2025HC Wainwright & Co.Edward WhiteMaintainedBuy$7
More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
TD Cowen Maintains Hold on Puma Biotechnology, Raises Price Target to $6

TD Cowen analyst Marc Frahm maintains Puma Biotechnology (NASDAQ:PBYI) with a Hold and raises the price target from $5 to $6.
Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Puma Biotechnology, Maintains $7 Price Target

HC Wainwright & Co. analyst Edward White reiterates Puma Biotechnology (NASDAQ:PBYI) with a Buy and maintains $7 price target.
Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Puma Biotechnology, Maintains $7 Price Target

HC Wainwright & Co. analyst Edward White reiterates Puma Biotechnology (NASDAQ:PBYI) with a Buy and maintains $7 price target.
Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Puma Biotechnology, Maintains $7 Price Target

HC Wainwright & Co. analyst Edward White reiterates Puma Biotechnology (NASDAQ:PBYI) with a Buy and maintains $7 price target.
Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Puma Biotechnology, Maintains $7 Price Target

HC Wainwright & Co. analyst Edward White reiterates Puma Biotechnology (NASDAQ:PBYI) with a Buy and maintains $7 price target.
Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Puma Biotechnology, Maintains $7 Price Target

HC Wainwright & Co. analyst Edward White reiterates Puma Biotechnology (NASDAQ:PBYI) with a Buy and maintains $7 price target.
Benzinga Newsdesk

Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API

Market data provided by Benzinga APIs

Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved